These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 2379158

  • 1. Determinants of the antitumor effect of radiolabeled monoclonal antibodies.
    Knox SJ, Levy R, Miller RA, Uhland W, Schiele J, Ruehl W, Finston R, Day-Lollini P, Goris ML.
    Cancer Res; 1990 Aug 15; 50(16):4935-40. PubMed ID: 2379158
    [Abstract] [Full Text] [Related]

  • 2. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
    Buchsbaum DJ, Khazaeli MB, Mayo MS, Roberson PL.
    Clin Cancer Res; 1999 Oct 15; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
    [Abstract] [Full Text] [Related]

  • 3. Therapy with unlabeled and 131I-labeled pan-B-cell monoclonal antibodies in nude mice bearing Raji Burkitt's lymphoma xenografts.
    Buchsbaum DJ, Wahl RL, Normolle DP, Kaminski MS.
    Cancer Res; 1992 Dec 01; 52(23):6476-81. PubMed ID: 1423295
    [Abstract] [Full Text] [Related]

  • 4. Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts.
    Ning S, Trisler K, Wessels BW, Knox SJ.
    Cancer; 1997 Dec 15; 80(12 Suppl):2519-28. PubMed ID: 9406705
    [Abstract] [Full Text] [Related]

  • 5. Treatment of intracranial human glioma xenografts with 131I-labeled anti-tenascin monoclonal antibody 81C6.
    Lee Y, Bullard DE, Humphrey PA, Colapinto EV, Friedman HS, Zalutsky MR, Coleman RE, Bigner DD.
    Cancer Res; 1988 May 15; 48(10):2904-10. PubMed ID: 2452014
    [Abstract] [Full Text] [Related]

  • 6. Therapeutic efficacy and tumor dose estimations in radioimmunotherapy of intraperitoneally growing OVCAR-3 cells in nude mice with (211)At-labeled monoclonal antibody MX35.
    Elgqvist J, Andersson H, Bäck T, Hultborn R, Jensen H, Karlsson B, Lindegren S, Palm S, Warnhammar E, Jacobsson L.
    J Nucl Med; 2005 Nov 15; 46(11):1907-15. PubMed ID: 16269606
    [Abstract] [Full Text] [Related]

  • 7. 131I radioimmunotherapy and fractionated external beam radiotherapy: comparative effectiveness in a human tumor xenograft.
    Barendswaard EC, O'Donoghue JA, Larson SM, Tschmelitsch J, Welt S, Finn RD, Humm JL.
    J Nucl Med; 1999 Oct 15; 40(10):1764-8. PubMed ID: 10520720
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM, Béhé M, Stabin MG, Wehrmann E, Apostolidis C, Molinet R, Strutz F, Fayyazi A, Wieland E, Gratz S, Koch L, Goldenberg DM, Becker W.
    Cancer Res; 1999 Jun 01; 59(11):2635-43. PubMed ID: 10363986
    [Abstract] [Full Text] [Related]

  • 10. Experimental radiotherapy of murine lymphoma with 131I-labeled anti-Thy 1.1 monoclonal antibody.
    Badger CC, Krohn KA, Peterson AV, Shulman H, Bernstein ID.
    Cancer Res; 1985 Apr 01; 45(4):1536-44. PubMed ID: 3978621
    [Abstract] [Full Text] [Related]

  • 11. Radioimmunotherapy of human B-cell chronic lymphocytic leukemia in nude mice.
    Zhu Z, Ghose T, Hoskin D, Lee CL, Fernandez LA, Lee SH, Mammen M.
    Cancer Res; 1994 Oct 01; 54(19):5111-7. PubMed ID: 7923127
    [Abstract] [Full Text] [Related]

  • 12. [Experimental study for the targeting therapy of mouse lung carcinoma treated by anti-hnRNPB1 monoclonal antibody with 131I].
    Chen MY, Li WM, Xu D, Chen WB.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Sep 01; 38(5):766-9. PubMed ID: 17953353
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Correlation of tumor sensitivity to low-dose-rate irradiation with G2/M-phase block and other radiobiological parameters.
    Knox SJ, Sutherland W, Goris ML.
    Radiat Res; 1993 Jul 01; 135(1):24-31. PubMed ID: 8327657
    [Abstract] [Full Text] [Related]

  • 15. Therapeutic efficacy of antiglioma mesenchymal extracellular matrix 131I-radiolabeled murine monoclonal antibody in a human glioma xenograft model.
    Lee YS, Bullard DE, Zalutsky MR, Coleman RE, Wikstrand CJ, Friedman HS, Colapinto EV, Bigner DD.
    Cancer Res; 1988 Feb 01; 48(3):559-66. PubMed ID: 2446747
    [Abstract] [Full Text] [Related]

  • 16. Enhanced antitumor activity of combination radioimmunotherapy (131I-labeled monoclonal antibody A33) with chemotherapy (fluorouracil).
    Tschmelitsch J, Barendswaard E, Williams C, Yao TJ, Cohen AM, Old LJ, Welt S.
    Cancer Res; 1997 Jun 01; 57(11):2181-6. PubMed ID: 9187118
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Fractionated radioimmunotherapy of human colon carcinoma xenografts with 131I-labeled monoclonal antibody CC49.
    Buchsbaum D, Khazaeli MB, Liu T, Bright S, Richardson K, Jones M, Meredith R.
    Cancer Res; 1995 Dec 01; 55(23 Suppl):5881s-5887s. PubMed ID: 7493364
    [Abstract] [Full Text] [Related]

  • 20. Targeting strategies for cancer radiotherapy.
    Buchsbaum DJ, Rogers BE, Khazaeli MB, Mayo MS, Milenic DE, Kashmiri SV, Anderson CJ, Chappell LL, Brechbiel MW, Curiel DT.
    Clin Cancer Res; 1999 Oct 01; 5(10 Suppl):3048s-3055s. PubMed ID: 10541342
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.